Cargando…

GABA(B)-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice

Some immune system cells express type A and/or type B γ-aminobutyric acid receptors (GABA(A)-Rs and/or GABA(B)-Rs). Treatment with GABA, which activates both GABA(A)-Rs and GABA(B)-Rs), and/or a GABA(A)-R-specific agonist inhibits disease progression in mouse models of type 1 diabetes (T1D), multipl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Jide, Middleton, Blake, Lee, Victoria Seunghee, Park, Hye Won, Zhang, Zhixuan, Kim, Bokyoung, Lowe, Catherine, Nguyen, Nancy, Liu, Haoyuan, Beyer, Ryan S., Chao, Hannah W., Chen, Ryan, Mai, Davis, O’Laco, Karen Anne, Song, Min, Kaufman, Daniel L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825043/ https://www.ncbi.nlm.nih.gov/pubmed/33418884 http://dx.doi.org/10.3390/biomedicines9010043

Ejemplares similares

GABA(A)-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice
por: Tian, Jide, et al.
Publicado: (2021)

GABA administration prevents severe illness and death following coronavirus infection in mice
por: Tian, Jide, et al.
Publicado: (2020)

Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted ß-Cells in Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2011)

Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication
por: Tian, Jide, et al.
Publicado: (2017)

Homotaurine Treatment Enhances CD4(+) and CD8(+) Regulatory T Cell Responses and Synergizes with Low-Dose Anti-CD3 to Enhance Diabetes Remission in Type 1 Diabetic Mice
por: Tian, Jide, et al.
Publicado: (2019)

GABA Administration Ameliorates Sjogren’s Syndrome in Two Different Mouse Models
por: Song, Min, et al.
Publicado: (2022)

The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19
por: Tian, Jide, et al.
Publicado: (2023)

Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2014)

A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice
por: Tian, Jide, et al.
Publicado: (2022)

Homotaurine, a safe blood-brain barrier permeable GABA(A)-R-specific agonist, ameliorates disease in mouse models of multiple sclerosis
por: Tian, Jide, et al.
Publicado: (2018)

A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human β-Cell Replication and Survival as well as GABA's Ability to Inhibit Inflammatory T Cells
por: Tian, Jide, et al.
Publicado: (2019)

NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
por: Wang, Dongjie
Publicado: (2022)

Retracted: NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Translocation of bacterial NOD2 agonist and its link with inflammation
por: Kim, Oh Yoen, et al.
Publicado: (2009)

Synthesis and validation of click-modified NOD1/2 agonists
por: Bharadwaj, Ravi, et al.
Publicado: (2023)

Molecular Characterization of Agonists That Bind to an Insect GABA Receptor†
por: McGonigle, Ian, et al.
Publicado: (2010)

GABA(B)-Agonistic Activity of Certain Baclofen Homologues
por: Attia, Mohamed I., et al.
Publicado: (2013)

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
por: Guzelj, Samo, et al.
Publicado: (2022)

Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases—The Case for Using Ignored Target Cell Antigen Determinants
por: Tian, Jide, et al.
Publicado: (2022)

Antitussive effects of the peripherally restricted GABA(B) receptor agonist lesogaberan in guinea pigs: comparison to baclofen and other GABA(B) receptor-selective agonists
por: Canning, Brendan J, et al.
Publicado: (2012)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists
por: Chen, Xia, et al.
Publicado: (2012)

Anxiolytics for Bronchodilation: Refinements to GABA(A) Agonists for Asthma Relief
por: Nayak, Ajay P., et al.
Publicado: (2022)

N-arylpyrazole NOD2 agonists promote immune checkpoint inhibitor therapy
por: Griffin, Matthew E., et al.
Publicado: (2023)

Limitations of Current GABA Agonists in Neonatal Seizures: Toward GABA Modulation Via the Targeting of Neuronal Cl(−) Transport
por: Khanna, Arjun, et al.
Publicado: (2013)

Augmentation of Tonic GABA(A) Inhibition in Absence Epilepsy: Therapeutic Value of Inverse Agonists at Extrasynaptic GABA(A) Receptors
por: Errington, Adam C., et al.
Publicado: (2011)

Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis
por: Bhattacharya, Dipankar, et al.
Publicado: (2021)

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2021)

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
por: Guzelj, Samo, et al.
Publicado: (2022)

γ-Hydroxybutyric Acid (GHB) Is Not an Agonist of Extrasynaptic GABA(A) Receptors
por: Connelly, William M., et al.
Publicado: (2013)

Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesia
por: Abe, Yoshifumi, et al.
Publicado: (2023)

T-cell agonists in cancer immunotherapy
por: Choi, Yeonjoo, et al.
Publicado: (2020)

NOD-Like Receptor Signaling in Cholesteatoma
por: Leichtle, Anke, et al.
Publicado: (2015)

Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2022)

Preliminary effects of pagoclone, a partial GABA(A) agonist, on neuropsychological performance
por: Caveney, Angela F, et al.
Publicado: (2008)

Image-Based Marker-Free Screening of GABA(A) Agonists, Antagonists, and Modulators
por: Rappaz, Benjamin, et al.
Publicado: (2019)

Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy
por: Janković, Slobodan M, et al.
Publicado: (2021)

GABA Receptor Agonists Protect From Excitotoxic Damage Induced by AMPA in Oligodendrocytes
por: Bayón-Cordero, Laura, et al.
Publicado: (2022)

GABA(B) receptor agonist baclofen promotes central nervous system remyelination
por: Serrano‐Regal, Mari Paz, et al.
Publicado: (2022)

Distinct Modulation of Spontaneous and GABA-Evoked Gating by Flurazepam Shapes Cross-Talk Between Agonist-Free and Liganded GABA(A) Receptor Activity
por: Jatczak-Śliwa, Magdalena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_elgdii9od734r1a4n9pps8muv7